JNC :: Journal of Neurocritical Care

| Home | E-Submission | Sitemap | Contact Us |

J Neurocrit Care

> Browse Articles > J Neurocrit Care

Successful treatment with rituximab in a patient with lupus cerebritis and posterior reversible encephalopathy syndrome: a case report

Saemi Choi, Young Seo Kim

J Neurocrit Care. 2021;14(2):103-108. Published online December 24, 2021

doi: https://doi.org/10.18700/jnc.210028

Cited By 1

Favorable clinical course after early-intensive immunotherapy for new-onset refractory status epilepticus

Hyun-Sung Kim, Jiyoung Kim, Bo-Jin Hwang, Kyoung-Nam Woo, Min-Gyu Park, Kyung-Pil Park, Sung-Ho Ahn

J Neurocrit Care. 2020;13(1):65-68. Published online June 15, 2020

doi: https://doi.org/10.18700/jnc.190115

Consciousness Recovery by Rituximab after Seizure Control in Cryptogenic New-Onset Refractory Status Epilepticus

Tae-Won Yang, Jeong Won Jo, Do-Hyung Kim, Young-Soo Kim, Oh-Young Kwon

J Neurocrit Care. 2018;11(2):137-142. Published online December 21, 2018

doi: https://doi.org/10.18700/jnc.180066

1 |

Volume 16, No. 2

E-Submission

Endnote Style File

Endnote Style File

Email Alert

Author's Index

SCImago Journal & Country Rank

Video clip

Supranuclear oculomotor palsy in cerebral venous sinus thrombosis: a case report. J Neurocrit Care. 2021;14:113-116

The author of the accepted manuscript will receive two mugs, printed with an abstract design. We look forward to your continued interest in and support for this journal.

Korean Neurocritical Care Society

First decision

15 Days

Publication after acceptance

40 Days

Submission to publication

79 Days

Acceptance rate

58 %

*Last 12 months

Editorial Office
Department of Neurology and Critical Care, Seoul National University Hospital,
101, Daehak-ro, Jongno-gu, Seoul, 03080 Korea
TEL: +82-2-2072-0743 (10:00 AM ~ 4:00 PM) / +82-2-2072-1810 FAX: +82-2-3672-7553 E-mail: office@e-jnc.org

Copyright© Korean Neurocritical Care Society.

Developed in M2PI